Carolyn Rucci
Conseiller Juridique Général chez AKEBIA THERAPEUTICS, INC.
Profil
Carolyn M.
Rucci is currently the Senior Vice President-Legal & General Counsel at Akebia Therapeutics, Inc. Prior to her current position, she served as the Vice President & Deputy General Counsel at AMAG Pharmaceuticals, Inc. from 2016 to 2021.
She also worked as a Principal at Wilmer Cutler Pickering Hale & Dorr LLP.
Ms. Rucci holds a graduate degree from Boston University School of Law and an undergraduate degree from Trinity College.
Postes actifs de Carolyn Rucci
| Sociétés | Poste | Début |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Conseiller Juridique Général | 01/01/2021 |
Anciens postes connus de Carolyn Rucci
| Sociétés | Poste | Fin |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/01/2021 |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Formation de Carolyn Rucci
| Trinity College | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Commercial Services |
